Ohio Public Employees Retirement System (OPERS)’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
+294,900
New +$351K ﹤0.01% 1570
2025
Q3
Sell
-27,200
Closed -$99K 2306
2025
Q2
$99K Buy
+27,200
New +$74.7K ﹤0.01% 1774
2023
Q1
Sell
-149,945
Closed -$87K 1988
2022
Q4
$87K Sell
149,945
-34,034
-18% -$10.7K ﹤0.01% 1491
2022
Q3
$58K Buy
+183,979
New +$72.2K ﹤0.01% 1815
2019
Q2
Sell
-30,240
Closed -$248K 1940
2019
Q1
$248K Buy
+30,240
New +$208K ﹤0.01% 1490

Other funds holding AKBA

Ohio Public Employees Retirement System (OPERS)'s AKBA Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) opened a new position in Akebia Therapeutics (AKBA) in Q2 2026: 294,900 shares worth $336K. The stake represents ﹤0.01% of the portfolio and ranks #1570 among its holdings. This is a return to the name: Ohio Public Employees Retirement System (OPERS) previously reported a position in AKBA as recently as Q2 2025.

Ohio Public Employees Retirement System (OPERS) first reported a position in AKBA in Q1 2019 and has held it in 5 quarters since. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 294,900 shares of Akebia Therapeutics worth $336K as of Q2 2026.
  • Akebia Therapeutics was a new Ohio Public Employees Retirement System (OPERS) position in Q2 2026.
  • Akebia Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1570 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Akebia Therapeutics in Q1 2019 and has held it in 5 quarters since.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.